Recurrent Metastatic Malignant Neoplasm

2

Review clinical trials related to Recurrent Metastatic Malignant Neoplasm. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA

This is a prospective, multicenter, observational real-world study to explore the Avapritinib therapy in GIST patients who definited Non-exon18 Mutations of PDGFRA.

Participants needed: 74
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Xinhua Zhang, MDUpdated: Feb 26, 2025Locations: 1
Eligibility criteria

Patients who are aged ≥ 18 years. [+6]

KIT or PDGFRA wild type. [+2]

Status: Recruiting

A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors

This is a prospective, multicenter, observational real-world study to explore the therapy patterns and clinical outcomes of Avapritinib in patients with metastatic or unresectable gastrointestinal stromal tumors.

Participants needed: 74
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Xinhua Zhang, MDUpdated: Feb 26, 2025Locations: 1
Eligibility criteria

Patients who are aged ≥ 18 years. [+6]

KIT or PDGFRA wild type. [+2]